These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1208643)

  • 1. Pharmacological effects of urotensins. I. Regional vascular effects of urotensins I and II in the rat.
    Medakovic M; Chan DK; Lederis K
    Pharmacology; 1975; 13(5):409-18. PubMed ID: 1208643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of urotensins. II. Renal effects of urotensin I in the rat.
    Medakovic M; Chan DK; Lederis K
    Pharmacology; 1975; 13(5):419-26. PubMed ID: 1208644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of urotensins. III. Fate or Urotensin I in different vascular beds and in blood of the rat.
    Medakovic M; Ruoff HJ; Lederis K
    Pharmacology; 1975; 13(5):427-32. PubMed ID: 1208645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by urotensin I, a selective mesenteric vasodilator peptide.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):284-91. PubMed ID: 3039111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo effects of human urotensin II in the rabbit and rat pulmonary circulation: effects of experimental pulmonary hypertension.
    Deuchar GA; Morecroft I; Dempsie Y; Herold N; Nilsen M; Hicks MN; MacLean MR
    Eur J Pharmacol; 2006 May; 537(1-3):135-42. PubMed ID: 16631735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of urotensins. IV. Blood pressure-lowering effects of urotensin I in spontaneously hypertensive rats.
    Medakovic M; Lederis K
    Pharmacology; 1975; 13(5):433-40. PubMed ID: 1208646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of the renal urotensin II system in the rat.
    Forty EJ; Ashton N
    Exp Physiol; 2012 Jun; 97(6):785-95. PubMed ID: 22327329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions.
    Watson AM; Lambert GW; Smith KJ; May CN
    Hypertension; 2003 Sep; 42(3):373-9. PubMed ID: 12885791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion.
    Fitzgibbons JP; Gennari FJ; Garfinkel HB; Cortell S
    J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urotensin-II: a novel systemic hypertensive factor in the cat.
    Behm DJ; Doe CP; Johns DG; Maniscalco K; Stankus GP; Wibberley A; Willette RN; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):274-80. PubMed ID: 14985938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal haemodynamic and tubular actions of urotensin II in the rat.
    Abdel-Razik AE; Forty EJ; Balment RJ; Ashton N
    J Endocrinol; 2008 Sep; 198(3):617-24. PubMed ID: 18577565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac output and its distribution during diving in the rat.
    Lin YC; Baker DG
    Am J Physiol; 1975 Mar; 228(3):733-7. PubMed ID: 1115238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic-independent anti-natriuretic effect of urotensin II in spontaneously hypertensive rats.
    Shi Y; Cao YX; Lu N; Yao T; Zhu YC
    Peptides; 2008 May; 29(5):783-94. PubMed ID: 18420307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana.
    Yano K; Hicks JW; Vaudry H; Conlon JM
    Gen Comp Endocrinol; 1995 Jan; 97(1):103-10. PubMed ID: 7713374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rat urotensin II on coronary flow and myocardial eNOS protein expression in isolated rat heart.
    Li L; Yuan WJ; Su DF
    Acta Pharmacol Sin; 2004 Nov; 25(11):1444-9. PubMed ID: 15525466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular actions of dogfish urotensin II in the dogfish Scyliorhinus canicula.
    Hazon N; Bjenning C; Conlon JM
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R573-6. PubMed ID: 8214148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous administration of prostacyclin on regional blood circulation in awake rats.
    Raczka E; Quintana A
    Br J Pharmacol; 1999 Mar; 126(6):1325-32. PubMed ID: 10217525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1147-54. PubMed ID: 2574741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
    Gardiner SM; March JE; Kemp PA; Maguire JJ; Kuc RE; Davenport AP; Bennett T
    Br J Pharmacol; 2006 Mar; 147(6):612-21. PubMed ID: 16314853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.